A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
about
Challenges to the clinical application of pluripotent stem cells: towards genomic and functional stabilityPrimordial germ cells in miceUbiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressorLack of p21 expression links cell cycle control and appendage regeneration in miceSwitching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologiesTumor suppressors: enhancers or suppressors of regeneration?Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspectiveDirect cell reprogramming is a stochastic process amenable to accelerationInduced neuronal cells: how to make and define a neuronUltraviolet Radiation-Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin AgingDissecting microRNA-mediated regulation of stemness, reprogramming, and pluripotencyPluripotent Stem Cells: Current Understanding and Future DirectionsInduced pluripotent stem cells in Parkinson's disease: scientific and clinical challengesHematopoietic Stem and Immune Cells in Chronic HIV InfectionConcise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem CellsGenome-editing tools for stem cell biologyEnergy metabolism plasticity enables stemness programsReprogramming of gastrointestinal cancer cellsMYC and the art of microRNA maintenanceConcise review: Oct4 and more: the reprogramming expresswayCellular reprogramming: a small molecule perspectiveShared mechanisms in stemness and carcinogenesis: lessons from oncogenic virusesLearning from a paradox: recent insights into Fanconi anaemia through studying mouse modelsEchoes of a distant past: The cag pathogenicity island of Helicobacter pyloriSirtuins in hematological aging and malignancyThe genomic stability of induced pluripotent stem cellsHematopoietic stem cell engineering at a crossroadsConcise review: Generation of neurons from somatic cells of healthy individuals and neurological patients through induced pluripotency or direct conversionOvercoming barriers to the clinical utilization of iPSCs: reprogramming efficiency, safety and qualityDirect lineage conversion: induced neuronal cells and induced neural stem cellsMechanisms of disseminated cancer cell dormancy: an awakening fieldCellular reprogramming in skin cancerTurning terminally differentiated skeletal muscle cells into regenerative progenitors.p53 suppresses muscle differentiation at the myogenin step in response to genotoxic stressChromatin structure of pluripotent stem cells and induced pluripotent stem cells.Examination of the expanding pathways for the regulation of p21 expression and activity.Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCsBalancing self-renewal against genome preservation in stem cells: How do they manage to have the cake and eat it too?Advances and Challenges on Cancer Cells Reprogramming Using Induced Pluripotent Stem Cells TechnologiesEmerging Non-Canonical Functions and Regulation by p53: p53 and Stemness
P2860
Q21183968-D353D61F-429D-4D2C-A095-4D787F5972B9Q22065789-8D62E623-1718-4E1E-9824-63BB393D3DADQ24337508-2AB7A885-B2E8-48BB-82D0-AEE046C0633DQ24600429-10D93A8B-EA22-4DF2-B2BE-26872100D46FQ24617141-EEDBDCCC-0D8C-4E78-88E6-413102401D24Q24618747-48B85873-C6C2-428D-8183-ADD7020A6414Q24633489-DAC4964E-FE35-4765-85A4-9B570D01A751Q24644898-DDDFAB56-3978-40A9-8500-039CF1E55C11Q26269839-A150F70A-8950-4AD1-A293-04595B73A943Q26752439-BA0460D1-2C4C-4578-BE82-B65E39BDBD6BQ26752448-6F6E4A8C-4047-422B-9C42-AAD82588CA18Q26769981-5A031642-E39D-42AE-AE32-6BF00B989254Q26772879-24046700-1C28-4ADF-8C14-B7915A9EA4F5Q26795450-7D211D05-9E8E-4809-A16E-E2ED33118C77Q26799570-A471FA06-BF22-4C28-88DD-40C4277CEB6CQ26800186-50D087D2-169A-4BA3-8639-B385F3A1ABBBQ26822945-17387580-D548-4E92-8F50-F5B54B876704Q26824284-A36C9BBC-9045-441B-9856-B659C1BD713CQ26825457-4228DBDB-A821-40C4-B3AD-4C3A9D655C87Q26827123-2C459C81-BEEC-4AF1-9179-60E3F3DEEDA2Q26829509-EB0A8F88-EFF1-4843-A7D7-ED47A6218C77Q26863339-77A02CFD-964C-47E6-9E8B-9492B5D797F8Q26863356-2826AA67-55DA-42AC-9E78-D4B7E70A5FBBQ26865877-25074AC5-7D50-482D-A3A0-BE9776B652FBQ26991467-6D8C1697-A51D-4977-9E98-52704B347075Q26998764-9059BB88-DB59-49AD-A98E-4D9AA038E17FQ27001570-C251B3B9-458E-4E81-8B84-730A07EA08B4Q27004350-3EC1ED8D-B5C4-4179-B0EB-A6EE83342E31Q27014026-582ABDFB-B191-427F-8163-BB5F4DCCE7ECQ27025605-A8C0BA35-3CDC-4D94-86A0-907E91B8501DQ27027015-82E68E7E-9199-4B5D-9F2C-C82E703E2B89Q27027468-755C9DDC-95B5-476F-A9D2-EF5024E2289EQ27323653-441DBCAE-3E38-4F3F-A978-B91456F555EFQ27331653-BF1D1F45-10CE-4873-A6F4-76ED6CADE0B1Q27691396-D1DE57B0-6E3F-4D75-BCC9-7026B58578D9Q27692024-F9FD1E36-9C50-402F-BFAF-F5DF4809DA8EQ28067268-EACD8895-7984-492F-9B3D-075718302910Q28070584-7FC53681-37F6-43FA-8D35-A276801160A9Q28071879-4751DF9C-1BA2-460F-95FD-163E9BA0DCDAQ28077156-A151397E-D6AA-4838-8A3B-FC4D73B3299A
P2860
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A p53-mediated DNA damage resp ...... ure iPS cell genomic integrity
@ast
A p53-mediated DNA damage resp ...... ure iPS cell genomic integrity
@en
type
label
A p53-mediated DNA damage resp ...... ure iPS cell genomic integrity
@ast
A p53-mediated DNA damage resp ...... ure iPS cell genomic integrity
@en
prefLabel
A p53-mediated DNA damage resp ...... ure iPS cell genomic integrity
@ast
A p53-mediated DNA damage resp ...... ure iPS cell genomic integrity
@en
P2093
P2860
P50
P3181
P356
P1433
P1476
A p53-mediated DNA damage resp ...... ure iPS cell genomic integrity
@en
P2093
Matilde Murga
Raquel Blanco
Rosa M Marión
Sagrario Ortega
P2860
P2888
P304
P3181
P356
10.1038/NATURE08287
P407
P577
2009-08-09T00:00:00Z
P5875
P6179
1009337647